Canopy Growth ROE 2018-2018 | CGC
Current and historical return on equity (ROE) values for Canopy Growth (CGC) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Canopy Growth ROE for the three months ending December 31, 2018 was -14.39%.
| Canopy Growth ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2018-12-31 | $-0.32B | $5.61B | -14.36% |
| 2018-09-30 | $-0.37B | $1.41B | -35.92% |
| 2018-06-30 | $-0.11B | $0.95B | -13.79% |
| 2018-03-31 | $-0.06B | $0.97B | -7.68% |
| 2017-12-31 | $-0.02B | $0.80B | -3.22% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $15.685B | $0.061B |
| Canopy Growth Corporation is a cannabis company. It offers dry cannabis and oil products primarily under the Tweed and Bedrocan brands. Canopy Growth Corporation is headquartered in Smiths Falls, Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $140.412B | 27.76 |
| Medtronic (MDT) | Ireland | $123.010B | 17.98 |
| Stryker (SYK) | United States | $73.467B | 26.97 |
| Boston Scientific (BSX) | United States | $52.473B | 25.58 |
| Baxter (BAX) | United States | $39.558B | 25.31 |
| Zimmer Biomet Holdings (ZBH) | United States | $26.051B | 16.68 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $17.542B | 0.00 |
| ResMed (RMD) | United States | $14.159B | 26.85 |
| Aurora Cannabis (ACB) | Canada | $9.930B | 70.07 |
| Bio-Rad Laboratories (BIO) | United States | $9.309B | 53.12 |
| Hill-Rom Holdings (HRC) | United States | $6.934B | 21.44 |
| Perrigo (PRGO) | Ireland | $6.569B | 10.65 |
| Insulet (PODD) | United States | $5.896B | 1989.40 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $5.140B | 0.00 |
| ICU Medical (ICUI) | United States | $4.857B | 30.24 |
| Haemonetics (HAE) | United States | $4.425B | 39.25 |
| Hutchison China MediTech (HCM) | China | $3.913B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $3.752B | 0.00 |
| Neogen (NEOG) | United States | $3.328B | 51.11 |
| NuVasive (NUVA) | United States | $2.858B | 24.93 |
| Quidel (QDEL) | United States | $2.654B | 23.95 |
| Aphria (APHA) | $2.533B | 112.44 | |
| National Vision Holdings (EYE) | United States | $2.263B | 44.51 |
| HEXO (HEXO) | $1.414B | 0.00 | |
| Cardiovascular Systems (CSII) | United States | $1.377B | 988.50 |
| VAREX IMAGING (VREX) | United States | $1.295B | 25.34 |
| Phibro Animal Health (PAHC) | United States | $1.292B | 18.57 |
| AtriCure (ATRC) | United States | $1.089B | 0.00 |
| MacroGenics (MGNX) | United States | $0.939B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.930B | 25.13 |
| Cerus (CERS) | United States | $0.874B | 0.00 |
| Omeros (OMER) | United States | $0.861B | 0.00 |
| PetIQ (PETQ) | United States | $0.843B | 24.12 |
| NanoString Technologies (NSTG) | United States | $0.751B | 0.00 |
| Meridian Bioscience (VIVO) | United States | $0.722B | 21.52 |
| OraSure Technologies (OSUR) | United States | $0.705B | 30.89 |
| Evolus (EOLS) | United States | $0.685B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.667B | 22.70 |
| TG Therapeutics (TGTX) | United States | $0.655B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $0.609B | 28.99 |
| Surmodics (SRDX) | United States | $0.603B | 87.71 |
| Quanterix (QTRX) | United States | $0.545B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.376B | 154.92 |
| Rockwell Medical (RMTI) | United States | $0.367B | 0.00 |
| Insys Therapeutics (INSY) | United States | $0.352B | 0.00 |
| Vapotherm (VAPO) | United States | $0.330B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.315B | 20.48 |
| Owens & Minor (OMI) | United States | $0.284B | 3.94 |
| Bovie Medical (APYX) | United States | $0.266B | 0.00 |
| Neptune Technologies & Bioresources Inc (NEPT) | Canada | $0.265B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.260B | 0.00 |
| Zynex (ZYXI) | United States | $0.144B | 15.37 |
| Fonar (FONR) | United States | $0.142B | 7.59 |
| Surface Oncology (SURF) | United States | $0.126B | 0.00 |
| Chimerix (CMRX) | United States | $0.102B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.099B | 0.00 |
| Female Health (VERU) | United States | $0.095B | 0.00 |
| United-Guardian (UG) | United States | $0.088B | 18.43 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.087B | 0.00 |
| InfuSystems Holdings (INFU) | United States | $0.086B | 0.00 |
| CAS Medical Systems (CASM) | United States | $0.071B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.070B | 20.71 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.057B | 0.00 |
| Neurotrope (NTRP) | United States | $0.055B | 0.00 |
| ImmuCell (ICCC) | United States | $0.038B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.037B | 0.00 |
| Senestech (SNES) | United States | $0.027B | 0.00 |
| Myomo (MYO) | United States | $0.021B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.017B | 0.00 |
| InVivo Therapeutics Holdings (NVIV) | United States | $0.016B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 16.00 |
